General Information of the Compound
Compound ID
CP0689211
Compound Name
3-[4-(2-Methoxy-phenyl)-piperazin-1-ylmethyl]-5-methylsulfanyl-2,3,5,6-tetrahydro-imidazo[1,2-c]quinazoline
    Show/Hide
Synonyms
3-[4-(2-Methoxyphenyl)piperazin-1-ylmethyl]-5-(methylsulfanyl)-2,3-dihydroimidazo[1,2-c]quinazoline
DL-017
    Show/Hide
Structure
Formula
C23H27N5OS
Molecular Weight
421.57
Canonical SMILES
COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1
    Show/Hide
InChI
InChI=1S/C23H27N5OS/c1-29-21-10-6-5-9-20(21)27-13-11-26(12-14-27)16-17-15-24-22-18-7-3-4-8-19(18)25-23(30-2)28(17)22/h3-10,17H,11-16H2,1-2H3
    Show/Hide
InChIKey
DVYBIZHLZSDANU-UHFFFAOYSA-N
Physicochemical Property
logP
3.3123
Rotatable Bonds
4
Heavy Atom Count
30
Polar Areas
43.67
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9931976
SID: 14904876
ChEMBL ID
CHEMBL1744044
Clinical Information about the Compound
Drug 1 ( DL-017 )
Drug Name DL-017
Indication
Hypertension
Phase 1
Target(s)
Adrenergic receptor alpha-1D (ADRA1D)
Modulator